Stock listing

Stuttgart:B6E Swedish Orphan Biovitrum AB Aktie

German listing (Stuttgart) of Swedish Orphan Biovitrum AB · home listing Stockholm:SOBI

Follow Swedish Orphan Biovitrum AB into a list and get an email when it puts out news.

Home listing price · OMXSTO:SOBI

490.20 SEK +2.20 (+0.5%)

Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXSTO:SOBI

Past year +47.8% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits

Day range: 485.40 – 491.00 SEKOct 30, 2026
Volume: 157,401 sharesOct 30, 2026
Market cap: 170.6B SEKAt the close on Oct 30, 2026 · price × 348.0M shares outstanding
52-week range: 314.40 – 492.00 SEKLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day: 143.1M SEKMedian day 266,947 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Prices by listing

Listing	Last	Change	Volume	Open	High	Low	Previous close	Price from
Stockholm:SOBI · Home	490.20 SEK	+2.20 (+0.5%)	157,401	488.00	491.00	485.40	488.00	Close on Oct 30, 2026
OTC:BIOVF	$45.72 USD	0.00 (0.0%)	—	$45.72	$45.72	$45.72	$45.72	Close on Oct 27, 2026
OTC:SWOBY	$20.28 USD	-1.487 (-6.8%)	621	$20.28	$20.28	$20.28	$21.77	Close on Oct 19, 2026
Frankfurt:B6E	€44.48 EUR	+2.78 (+6.7%)	—	€44.48	€44.48	€44.48	€41.70	Close on Oct 30, 2026
Munich:B6E	€42.82 EUR	+2.14 (+5.3%)	—	€42.24	€42.82	€42.24	€40.68	Close on Oct 27, 2026

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OMXSTO:SOBI · SEK, adjusted for splits

Day	Close	Change	%	Open	High	Low	Volume
Fri, Oct 30	490.20	+2.20	+0.5%	488.00	491.00	485.40	157,401
Thu, Oct 29	488.00	+9.80	+2.0%	476.60	492.00	473.80	421,032
Wed, Oct 28	478.20	+14.20	+3.1%	478.00	484.40	469.00	839,985
Tue, Oct 27	464.00	+5.00	+1.1%	475.00	478.00	451.20	618,400
Mon, Oct 26	459.00	+4.80	+1.1%	454.60	461.60	454.60	380,326
Fri, Oct 23	454.20	+2.20	+0.5%	452.60	454.20	440.60	447,532
Thu, Oct 22	452.00	-6.40	-1.4%	448.00	454.40	444.40	235,831
Wed, Oct 21	458.40	+11.80	+2.6%	446.60	458.40	445.60	484,043
Tue, Oct 20	446.60	+9.40	+2.2%	440.00	447.80	437.40	357,809
Mon, Oct 19	437.20	+0.80	+0.2%	437.60	440.00	431.00	196,624
Fri, Oct 16	436.40	-4.80	-1.1%	439.80	441.80	431.60	338,935
Thu, Oct 15	441.20	+3.80	+0.9%	437.80	443.20	435.40	239,736
Wed, Oct 14	437.40	+10.20	+2.4%	427.40	438.00	424.80	372,805
Tue, Oct 13	427.20	-6.40	-1.5%	433.60	437.40	420.40	397,854
Mon, Oct 12	433.60	+5.20	+1.2%	431.00	435.40	430.00	192,374
Fri, Oct 9	428.40	+6.00	+1.4%	427.60	431.60	426.60	180,121
Thu, Oct 8	422.40	-11.00	-2.5%	430.20	430.20	421.20	252,368
Wed, Oct 7	433.40	+4.80	+1.1%	426.40	434.80	426.40	208,067
Tue, Oct 6	428.60	+3.80	+0.9%	430.60	435.20	424.60	372,317
Mon, Oct 5	424.80	-3.00	-0.7%	427.00	432.40	423.40	187,914
Fri, Oct 2	427.80	-6.60	-1.5%	430.20	436.20	425.60	232,979
Thu, Oct 1	434.40	-6.00	-1.4%	440.40	443.20	434.40	239,736
Wed, Sep 30	440.40	+3.80	+0.9%	439.60	445.00	437.20	229,807
Tue, Sep 29	436.60	-2.80	-0.6%	438.80	443.40	435.00	204,001
Mon, Sep 28	439.40	+3.20	+0.7%	437.20	442.20	435.00	266,947
Fri, Sep 25	436.20	+0.20	0.0%	438.00	443.60	436.20	229,017
Thu, Sep 24	436.00	-3.60	-0.8%	438.20	439.80	433.40	360,637
Wed, Sep 23	439.60	-8.60	-1.9%	444.20	449.40	439.60	243,964
Tue, Sep 22	448.20	+4.60	+1.0%	443.00	450.40	440.80	248,643
Mon, Sep 21	443.60	-3.40	-0.8%	448.00	452.20	439.80	370,246
Fri, Sep 18	447.00	+1.20	+0.3%	445.80	453.80	443.40	478,323
Thu, Sep 17	445.80	+6.40	+1.5%	444.00	448.60	440.40	322,534
Wed, Sep 16	439.40	-0.20	0.0%	441.80	446.40	438.60	251,089
Tue, Sep 15	439.60	-8.60	-1.9%	448.20	449.20	435.40	209,628
Mon, Sep 14	448.20	+9.80	+2.2%	438.80	452.00	438.00	208,015
Fri, Sep 11	438.40	-0.40	-0.1%	437.20	445.20	432.00	147,154
Thu, Sep 10	438.80	-4.40	-1.0%	445.40	446.00	438.80	139,275
Wed, Sep 9	443.20	-13.80	-3.0%	453.20	454.20	442.60	251,626
Tue, Sep 8	457.00	+7.00	+1.6%	455.20	461.20	451.00	323,789
Mon, Sep 7	450.00	-4.80	-1.1%	454.00	455.00	450.00	132,533
Fri, Sep 4	454.80	-5.20	-1.1%	460.40	461.40	453.20	280,388
Thu, Sep 3	460.00	+5.00	+1.1%	456.00	465.60	456.00	190,954
Wed, Sep 2	455.00	-2.40	-0.5%	457.20	463.40	454.00	322,823
Tue, Sep 1	457.40	+7.60	+1.7%	450.00	459.80	450.00	422,644
Mon, Aug 31	449.80	-16.40	-3.5%	463.60	463.80	449.80	590,889
Fri, Aug 28	466.20	-1.60	-0.3%	468.00	471.00	466.20	186,782
Thu, Aug 27	467.80	+3.60	+0.8%	463.40	470.00	460.00	208,120
Wed, Aug 26	464.20	-5.40	-1.1%	469.60	469.80	462.40	194,170
Tue, Aug 25	469.60	+17.60	+3.9%	454.20	469.60	453.80	290,945
Mon, Aug 24	452.00	-8.00	-1.7%	458.80	458.80	450.60	175,379
Fri, Aug 21	460.00	-1.40	-0.3%	461.80	462.20	457.40	249,734
Thu, Aug 20	461.40	-4.20	-0.9%	467.40	469.40	456.40	199,711
Wed, Aug 19	465.60	+1.00	+0.2%	464.60	469.60	462.80	282,687
Tue, Aug 18	464.60	+6.80	+1.5%	458.40	465.80	454.00	382,440
Mon, Aug 17	457.80	+17.40	+4.0%	440.40	457.80	439.60	327,968
Fri, Aug 14	440.40	-8.20	-1.8%	446.80	448.40	434.40	262,661
Thu, Aug 13	448.60	+3.80	+0.9%	445.00	449.80	443.80	210,730
Wed, Aug 12	444.80	+3.40	+0.8%	442.20	447.00	439.00	192,177
Tue, Aug 11	441.40	-9.00	-2.0%	441.60	453.60	440.40	614,060
Mon, Aug 10	450.40	-2.80	-0.6%	453.20	459.80	449.40	277,740
Fri, Aug 7	453.20	+7.40	+1.7%	446.00	459.20	445.60	421,291
Thu, Aug 6	445.80	+5.00	+1.1%	442.40	445.80	440.00	318,692
Wed, Aug 5	440.80	+4.60	+1.1%	437.20	446.40	434.40	306,646
Tue, Aug 4	436.20	+0.20	0.0%	440.40	441.80	434.20	382,140
Mon, Aug 3	436.00	-34.60	-7.4%	463.80	463.80	432.40	929,374
Fri, Jul 31	470.60	-2.00	-0.4%	474.00	480.20	468.80	528,345
Thu, Jul 30	472.60	-0.60	-0.1%	473.20	476.00	469.80	573,406

Ticker: Stuttgart:B6E
Asset type: Stock
Exchange: Stuttgart
Currency: EUR

What changed lately

Latest news release · Oct 29, 2026
Börje Ekholm is proposed as new Chair of the Sobi Board of Directors
Latest earnings call · Oct 27, 2026
Swedish Orphan Biovitrum (Stockholm:SOBI) Q3 2026 Earnings Call
Replay and transcript
Watch replay
Latest deck · Oct 27, 2026
Q3 2026 Earnings Presentation
Earnings · 27 slides

Calls

Replays

Swedish Orphan Biovitrum (Stockholm:SOBI) Q3 2026 Earnings Call
Tue, Oct 27, 2026 · 10:00 AM ET
Watch Transcript
Swedish Orphan Biovitrum (Stockholm:SOBI) Q2 2026 Earnings Call
Thu, Jul 16, 2026 · 8:00 AM ET
Watch Transcript
Swedish Orphan Biovitrum (Stockholm:SOBI) Q1 2026 Earnings Call
Tue, Apr 28, 2026 · 6:30 AM ET
Watch Transcript

Latest news

Börje Ekholm is proposed as new Chair of the Sobi Board of Directors

Oct 29, 2026

Closed 490.20 (+0.5%) on Oct 30, 2026

Swedish Orphan Biovitrum: Sobi receives positive CHMP opinion for TRYNGOLZA (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

Oct 16, 2026

Closed 436.40 (-1.1%) on Oct 16, 2026

Invitation: Sobi's Q3 2026 report

Oct 8, 2026

Closed 422.40 (-2.5%) on Oct 8, 2026

Change in number of shares and votes in Sobi

Sep 30, 2026

Closed 440.40 (+0.9%) on Sep 30, 2026

Sobi and Innate announce partnership is now effective following completion of closing conditions

Sep 16, 2026

Closed 445.80 (+1.5%) on Sep 17, 2026

Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome

Sep 9, 2026

Closed 438.80 (-1.0%) on Sep 10, 2026

Sobi has completed an issue of class C shares

Aug 31, 2026

Closed 449.80 (-3.5%) on Aug 31, 2026

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

Aug 10, 2026

Closed 450.40 (-0.6%) on Aug 10, 2026

Guido Oelkers to step down as CEO of Sobi in the beginning of 2027

Aug 3, 2026

Closed 436.00 (-7.4%) on Aug 3, 2026

Sobi Q2 2026 report: Significant growth with important pipeline progress

Jul 16, 2026

Closed 465.80 (+2.1%) on Jul 16, 2026

All Swedish Orphan Biovitrum AB news

Decks

Q3 2026 Earnings Presentation
Earnings · 27 slides · Oct 27, 2026
Q3 2026 Earnings Presentation
Earnings · 37 slides · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 38 slides · October 2026
Q2 2026 Earnings Presentation
Earnings · 27 slides · Jul 16, 2026

Swedish Orphan Biovitrum AB on 6ix

News releases: 46 in the last 12 months · 72 in all · newest Oct 29, 2026 · oldest 2025
Calls: 15 calls with a replay · 15 with a transcript · latest Oct 27, 2026
Decks: 86 decks · latest Oct 27, 2026

Where Swedish Orphan Biovitrum AB is listed

Listing	Exchange	Country	Currency
Stockholm:SOBI · Home listing	Stockholm	Sweden	SEK
OTC:BIOVF	OTC	United States	USD
OTC:SWOBY	OTC	United States	USD
gettex:B6E	gettex	Germany	EUR
Milan:1SOBI	Milan	Italy	EUR
LSIN:0MTD	LSIN	United Kingdom	SEK
Aquis:SOBIS	Aquis	United Kingdom	SEK
BMV:SOBIN	BMV	Mexico	MXN
LS Exchange:A0LA5K	LS Exchange	Germany	EUR
Lang & Schwarz:A0LA5K	Lang & Schwarz	Germany	EUR
BIVA:SOBIN	BIVA	Mexico	MXN
Frankfurt:B6E	Frankfurt	Germany	EUR
Aquis:SOBIS	Aquis	United Kingdom	SEK
Turquoise:SOBIS	Turquoise	United Kingdom	SEK
Dusseldorf:B6E	Dusseldorf	Germany	EUR
Hamburg:B6E	Hamburg	Germany	EUR
Hanover:B6E	Hanover	Germany	EUR
Munich:B6E	Munich	Germany	EUR
Stuttgart:B6E · This page	Stuttgart	Germany	EUR
Tradegate:B6E	Tradegate	Germany	EUR

Stuttgart:B6E Swedish Orphan Biovitrum AB Aktie

Prices by listing

Daily closes

What changed lately

Börje Ekholm is proposed as new Chair of the Sobi Board of Directors

Swedish Orphan Biovitrum (Stockholm:SOBI) Q3 2026 Earnings Call

Q3 2026 Earnings Presentation

Calls

Replays

Latest news

Börje Ekholm is proposed as new Chair of the Sobi Board of Directors

Swedish Orphan Biovitrum: Sobi receives positive CHMP opinion for TRYNGOLZA (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

Invitation: Sobi's Q3 2026 report

Change in number of shares and votes in Sobi

Sobi and Innate announce partnership is now effective following completion of closing conditions

Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome

Sobi has completed an issue of class C shares

Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma

Guido Oelkers to step down as CEO of Sobi in the beginning of 2027

Sobi Q2 2026 report: Significant growth with important pipeline progress

Decks

Q3 2026 Earnings Presentation

Q3 2026 Earnings Presentation

Investor Presentation (October 2026)

Q2 2026 Earnings Presentation

Swedish Orphan Biovitrum AB on 6ix

Where Swedish Orphan Biovitrum AB is listed